使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
As a reminder, this call is being recorded.
提醒各位,本次電話會議正在錄音。
William Brent Turner - President
William Brent Turner - President
Good morning. I'm Brent Turner, President of Acadia Healthcare, and I'd like to welcome you to our First Quarter 2017 Conference Call.
早安。我是 Acadia Healthcare 總裁 Brent Turner,歡迎各位參加我們 2017 年第一季電話會議。
To the extent any non-GAAP financial measures are discussed in today's call, you will also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by following yesterday's news release under the Investors link.
若今日電話會議中討論任何非 GAAP 財務衡量指標,您也可在我們網站上,透過「投資人」連結下昨日新聞稿,找到該指標與依 GAAP 計算之最直接可比財務指標的調節表。
This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements, among others, regarding Acadia's expected quarterly and annual financial performance for 2017 and beyond. For this purpose, any statements made during the call that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words believes, anticipates, plans, expects and similar expressions are intended to identify forward-looking statements.
本次電話會議可能包含《1995 年私人證券訴訟改革法》所定義的前瞻性陳述,其中包括但不限於關於 Acadia 對 2017 年及其後預期的季度與年度財務表現之陳述。就此而言,會議中任何非歷史事實的陳述,均可能被視為前瞻性陳述。在不限制前述內容的情況下,believes、anticipates、plans、expects 及類似用語旨在辨識前瞻性陳述。
You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Acadia's filings with the Securities and Exchange Commission and in the company's first quarter news release. And consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements. The company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
特此提醒您,這些陳述可能受到多項重要因素影響(其中包括但不限於)Acadia 向美國證券交易委員會提交之文件及公司第一季新聞稿中所載之因素。因此,實際營運與結果可能與前瞻性陳述中討論的結果存在重大差異。公司不承擔公開更新任何前瞻性陳述之義務,不論係因新資訊、未來事件或其他原因。
At this time, for opening remarks, I'll now turn the conference call over to our Chairman and Chief Executive Officer, Joey Jacobs.
此刻,作為開場致詞,我將把電話會議交給我們的董事長兼執行長 Joey Jacobs。
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Good morning, and welcome to our First Quarter Conference Call. In addition to Brent, I'm here today with our Chief Financial Officer, David Duckworth, and other members of our executive management team. David and I each have some remarks about the first quarter and our outlook for Acadia, then we'll open the line for your questions.
早安,歡迎各位參加我們的第一季電話會議。除了 Brent 之外,今天與我一同出席的還有我們的財務長 David Duckworth,以及其他執行管理團隊成員。David 和我將分別就第一季表現與 Acadia 的展望發表一些談話,之後我們將開放線路供各位提問。
Our results for the first quarter were consistent with our expectations, and we were pleased that our adjusted earnings per diluted share of $0.46 met our guidance for the quarter. Please note that our results for the first quarter were affected by the divestiture of the 22 facilities in the U.K. during the fourth quarter of 2016 and the 14% decline in dollar pound exchange rate from the first quarter of 2016.
我們第一季的結果符合預期,且我們很高興調整後稀釋每股盈餘為 0.46 美元,達到本季指引。請注意,我們第一季的結果受到 2016 年第四季在英國處分 22 家機構,以及相較 2016 年第一季英鎊兌美元匯率下跌 14% 的影響。
With leap year in the first quarter of 2016, we also had 1 less day in the first quarter of 2017. Adjusting for that difference, this year's first quarter U.S. same-facility staff would increase by 110 basis points. Despite these factors, we produced solid financial and operating results for the quarter, and we expect to achieve our financial guidance for the year.
由於 2016 年第一季為閏年,2017 年第一季也因此少了 1 天。若調整該差異,今年第一季美國同院所(same-facility)staff 將增加 110 個基點。儘管有上述因素,我們本季仍繳出穩健的財務與營運成果,並預期可達成全年財務指引。
Acadia's revenue growth for the quarter was primarily driven by the addition of a net 6,200 beds through the Priory acquisition halfway through the first quarter last year. We initiated full integration of Priory into Acadia after the U.K. facility divestiture in November 2016. By the end of the first quarter of 2017, we had achieved about $16 million of the expected $20 million of cost synergies from the transaction, and we expect to recognize all the cost synergies by the fourth quarter of this year.
Acadia 本季營收成長主要來自於去年第一季中段完成 Priory 收購案後,淨增加 6,200 張床位。在 2016 年 11 月完成英國機構處分後,我們啟動將 Priory 全面整合至 Acadia。截至 2017 年第一季末,我們已實現預期 2,000 萬美元成本綜效中的約 1,600 萬美元,並預期在今年第四季前認列全部成本綜效。
In addition to the Priory beds, we added just over 950 beds during the trailing 12 months ended March 31, 2017, through 3 U.S. acquisitions and the addition of 719 beds to existing facilities and de novo facilities. 82 of these organic beds were added during the first quarter of 2017. We expect to add over 800 new beds organically for all of 2017 primarily to existing facilities and through 3 de novo facilities scheduled for opening in the second half of 2017.
除 Priory 的床位外,截至 2017 年 3 月 31 日止的過去 12 個月,我們亦透過 3 項美國收購案,以及在既有機構與新設(de novo)機構新增 719 張床位,合計新增略高於 950 張床位。其中有 82 張有機成長床位是在 2017 年第一季新增。我們預期 2017 年全年將以有機方式新增超過 800 張新床位,主要來自既有機構擴充,以及預計於 2017 年下半年開業的 3 家新設(de novo)機構。
We believe while the factors that we faced during the first quarter had an impact on the quarter, they did not meaningfully affect the favorable long-term market dynamics of the behavioral health of the industry in the U.S. and the U.K. or Acadia's ability to produce long-term profitable growth and increased shareholder value by successfully executing our proven business model. With long-term trends of increasing demand and access expected to continue, we expect ongoing industry capacity constraints and rising consolidation pressures will continue to provide Acadia opportunities to successfully implement its acquisition and organic growth strategy.
我們認為,雖然第一季所面臨的因素對本季造成影響,但並未實質改變美國與英國行為健康產業有利的長期市場動態,也未實質影響 Acadia 透過成功執行我們經驗證的商業模式,以實現長期獲利成長並提升股東價值的能力。隨著需求增加與可近性提升等長期趨勢預期將持續,我們預期產業產能限制與整併壓力上升仍將持續,並將為 Acadia 成功推動其併購與有機成長策略提供機會。
Thank you for this time -- your time this morning and your interest in Acadia. Now, David Duckworth will take you through some of the financials.
感謝各位今天早上撥冗以及對 Acadia 的關注。接下來,David Duckworth 將帶各位回顧部分財務數據。
David M. Duckworth - CFO, CAO and Controller
David M. Duckworth - CFO, CAO and Controller
Thanks, Joey, and good morning. Acadia's revenue for the first quarter of 2017 was $679.2 million, up 10.1% from $616.8 million for the first quarter of 2016. Adjusted income attributable to Acadia stockholders was $39.9 million or $0.46 per diluted share for the first quarter of 2017 compared with $45.8 million or $0.55 per diluted share for the first quarter last year.
謝謝你,Joey,早安。Acadia 2017 年第一季營收為 6.792 億美元,較 2016 年第一季的 6.168 億美元成長 10.1%。2017 年第一季歸屬於 Acadia 股東的調整後淨利為 3,990 萬美元,或調整後稀釋每股盈餘 0.46 美元;相較去年第一季為 4,580 萬美元,或調整後稀釋每股盈餘 0.55 美元。
Adjusted diluted EPS for the latest quarter excludes transaction related expenses of $4.1 million. For the first quarter of 2016, adjusted diluted EPS excludes transaction related expenses of $26.3 million and a gain on foreign currency derivatives of $410,000.
最新一季的調整後稀釋每股盈餘排除 410 萬美元的交易相關費用。2016 年第一季的調整後稀釋每股盈餘排除 2,630 萬美元的交易相關費用,以及 41 萬美元的外匯衍生性金融工具收益。
On a constant currency basis, Acadia's revenue increased 16.2% to $716.7 million for the first quarter of 2017. Adjusted income from continuing operations attributable to Acadia stockholders on a constant currency basis was $43.8 million or $0.50 per diluted share.
以固定匯率(constant currency)計算,Acadia 2017 年第一季營收成長 16.2% 至 7.167 億美元。以固定匯率計算,歸屬於 Acadia 股東之持續營業單位調整後淨利為 4,380 萬美元,或調整後稀釋每股盈餘 0.50 美元。
Acadia's tax rate on adjusted income from continuing operations before income taxes was 24.5% for the first quarter of 2017 compared with 21.9% for the first quarter of 2016.
Acadia 2017 年第一季持續營業單位調整後稅前淨利的稅率為 24.5%,相較 2016 年第一季為 21.9%。
Same-facility adjusted EBITDA margin was 25.2% compared with 25.6% for the first quarter of 2016. Comparable quarter consolidated adjusted EBITDA was $136.4 million, an increase of 4.1% from $131 million for the first quarter of 2016.
同院所(same-facility)調整後 EBITDA 利潤率為 25.2%,相較 2016 年第一季為 25.6%。可比季度的合併調整後 EBITDA 為 1.364 億美元,較 2016 年第一季的 1.31 億美元成長 4.1%。
Acadia's operating cash flow from continuing operations was $57.4 million for the first quarter of 2017.
Acadia 2017 年第一季持續營業單位的營運活動現金流量為 5,740 萬美元。
Turning to our financial guidance and as announced in yesterday afternoon's news release, we are affirming our 2017 financial guidance, which includes revenue in the range of $2.85 billion to $2.9 billion; adjusted EBITDA in the range of $625 million to $640 million; and adjusted diluted EPS in the range of $2.40 to $2.50. This guidance assumes an exchange rate of $1.25 per British pound Sterling and a tax rate of approximately 25%.
接著談我們的財務指引;如同昨日下午新聞稿所宣布,我們重申 2017 年財務指引,包括:營收介於 28.5 億至 29 億美元;調整後 EBITDA 介於 6.25 億至 6.40 億美元;以及調整後稀釋每股盈餘介於 2.40 至 2.50 美元。此指引假設匯率為每 1 英鎊兌 1.25 美元,且稅率約為 25%。
Our financial guidance does not include the impact from any future acquisitions or transaction related expenses.
我們的財務指引未包含任何未來收購案或交易相關費用的影響。
This concludes our prepared remarks this morning, and thank you for being with us. I will now ask Ebony to open up the floor for your questions.
以上為我們今天早上的準備致詞,感謝各位與會。接下來我將請 Ebony 開放現場供各位提問。
Operator
Operator
(Operator Instructions) And we'll take our first question from A.J. Rice from UBS. And we will (inaudible) from (inaudible)
(接線員指示) 我們將開始第一個提問,來自 UBS 的 A.J. Rice。另外我們將(聽不清)來自(聽不清)
Unidentified Analyst
Unidentified Analyst
Top line in the quarter, a little bit softer. I guess did you see anything as the quarter progressed? Maybe talk about any issues in the U.K. -- specifically aside from distraction after Priory. And I guess just help frame your comforting and confidence in revenue and EBITDA guidance ramp as we sort of move through the year?
本季營收端(Top line)稍微偏弱一些。我想問的是,隨著季度推進,你們有看到任何變化嗎?也請談談英國方面是否有任何問題——特別是撇除 Priory 之後分心的因素。另外也請協助我們理解,當我們在今年接下來的時間往前走時,你們對營收與 EBITDA 指引逐季爬升的安心程度與信心來源?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Well, obviously, by reaffirming the guidance in our press release and now on the call, we're comfortable with our total year guidance. And as -- if you follow the history of the industry and of this company, usually, our softest quarter is the first quarter and then we begin to have a ramp-up in the quarter starting in the second quarter. So I think for the last 3 quarters each, we need about $0.66 to hit the guidance, and I think that's very doable and we're working very hard to make that happen.
嗯,顯然,我們在新聞稿中重申指引,現在在電話會議上也再次重申,代表我們對全年總體指引感到放心。而且——如果你回顧這個產業以及本公司的歷史,通常第一季是我們最疲弱的一季,接著從第二季開始就會逐季拉升。所以我認為接下來每一季大概需要約 0.66 美元才能達到指引,我覺得這非常可行,我們也正非常努力讓它發生。
Unidentified Analyst
Unidentified Analyst
Okay, fair enough. And then just wanted to ask on the margin side as well, strong results with margin expansion in the U.K., even on the 2.6% same-facility revenue side and then conversely, 90 bps of pressure on the 5.5% in the U.S. Can you maybe just talk about the dynamics there, the sustainability and the margin expansion in the U.K. and maybe what led to some of the pressures in the U.S. despite pretty healthy same-store growth?
好的,合理。另外也想問一下毛利率(margin)方面:英國的表現很強,即使同院(same-facility)營收只有 2.6% 的成長,毛利率仍在擴張;相對地,美國同店 5.5% 的成長下,毛利率卻承受 90 個基點的壓力。你能否談談其中的動態、英國毛利率擴張的可持續性,以及美國在同店成長相當健康的情況下,壓力來自哪些因素?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
I think due to the size of the company, small movement, whether it's coming in just a little light on the revenue or a little more over on the expenses, makes that 90 basis points occur in the margins. So we are staffed and positioned to improve our profit margins going forward. We expect the U.K. to continue to work through the integration and to consolidate the 2 companies and to implement their marketing and growth plans there. So we're very positive about the outlook for the margins, both for the U.K. and for the U.S.
我認為以公司的規模來看,些微的變動——不論是營收稍微低一點,或是費用稍微高一點——都可能導致毛利率出現那 90 個基點的變化。因此,我們在人力配置與營運定位上,都是為了在未來提升利潤率。我們預期英國將持續推進整合、把兩家公司整併起來,並在當地落實其行銷與成長計畫。所以我們對英國與美國的毛利率展望都非常正面。
Operator
Operator
And (inaudible) A.J. Rice, UBS.
(聽不清)A.J. Rice,UBS。
Albert J. Rice - MD and Equity Research Analyst, Healthcare Facilities
Albert J. Rice - MD and Equity Research Analyst, Healthcare Facilities
First of all, maybe just quickly on the redeploying of the Priory proceeds, I know that you're hoping to redeploy that in the U.S., can you just update us on what you see in acquisition wise, pipeline, that type of thing?
首先,關於 Priory 出售所得的再部署(redeploying)方面,我知道你們希望把這些資金再部署到美國;能否更新一下你們在併購方面看到的情況、案源管線(pipeline)之類的進展?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
The pipeline is -- we're as busy as we've ever been. After this call today, a group of us are going to be a making a trip to meet with a party about a joint venture. And with me going, I think that means we're getting close to seeing that happen. So there's a lot of activity on the pipeline. And then on the larger transactions, there'll be a couple of those that will come to the market and would be actionable this year if we so desire to do them and if the due diligence holds up to our standards of the past. So that pipeline is busy. The joint venture opportunities are numerous. And the larger transaction, there'll be a couple this year that will be actionable if they get through our due diligence process, we can make that happen.
我們的案源管線——我們跟以往任何時候一樣忙。今天這通電話會議結束後,我們其中一組人會出發去和某一方會面,討論一個合資(joint venture)。而我也會一起去,我想這代表我們距離促成這件事已經很接近了。所以管線上有很多活動。至於較大型的交易,今年會有幾筆會進到市場;如果我們有意願做、而且盡職調查(due diligence)也能符合我們過去一貫的標準,那今年就會是可執行(actionable)的。所以這條管線很忙。合資機會很多。而大型交易今年也會有幾筆,只要通過我們的盡職調查流程,我們就能把它做成。
Albert J. Rice - MD and Equity Research Analyst, Healthcare Facilities
Albert J. Rice - MD and Equity Research Analyst, Healthcare Facilities
Okay. And then just maybe a follow-up on the labor side, any update on what you're seeing in terms of availability of both clinicians and psychiatrist? And how's that pipeline look? And what are you seeing there?
好的。另外再追問一下勞動力方面:你們對臨床人員與精神科醫師的供給可得性,有沒有新的觀察?那個招募管線看起來如何?你們目前看到的是什麼情況?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Here in the U.S., we're doing an excellent job on attracting physicians and the technical individuals that we will need for our facilities to meet our patient's demand. The real shortage is over in the U.K. where there is a nursing shortage over there. But we have a plan there to be more efficient there and to use less agencies expense there. So the U.S., we're doing fine and working through any labor issues or shortage of labor issues in any market. And then the U.K., we're working on a strategy on how do we attract more nurses, make it the place to work for in the U.K.
在美國這邊,我們在吸引醫師以及我們設施為了滿足病患需求所需的技術人員方面,做得非常好。真正的短缺是在英國,那邊有護理人員短缺。不過我們在那邊有一個計畫,要提升效率並降低對人力派遣機構(agencies)費用的依賴。所以美國這邊我們狀況良好,也正在處理各市場可能出現的任何勞動力問題或短缺問題。至於英國,我們正在制定策略:如何吸引更多護理人員,讓我們成為英國最想來工作的地方。
Operator
Operator
Our next question is from [ Brian ] (inaudible).
下一個提問來自 [ Brian ](聽不清)。
Unidentified Analyst
Unidentified Analyst
My first question, Joey, just one concern that we've heard from investors is your exposure to the Affordable Care Act if that is repealed and replaced by Congress. So I just want to hear your thoughts on what benefit do you thank you had seen over the years with the ACA. And based on what we've seen in terms of the draft, what do you think is the true exposure that Acadia has if the ACA is indeed repealed?
我的第一個問題,Joey,我們從投資人那邊聽到的一個疑慮是:如果《平價醫療法案》(Affordable Care Act,ACA)被國會廢除並以新法取代,你們的曝險程度。所以我想聽聽你的看法:多年來你認為 ACA 帶給你們的好處是什麼?以及根據我們目前看到的草案內容,如果 ACA 真的被廢除,Acadia 真正的曝險會是什麼?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
We think the exposure to this, both positive and negative is a very small, but we'll have to wait and see. Access to mental health benefits, everyone wants that to happen. Now during the process of changing the healthcare law, if that is possible and if they have the votes to do that, we'll just have to wait and see. But the demand for our services and employers and state, realize the importance of covering those individuals and their families, so this is a -- as we stated with the ACA when it first came in that it was more of a neutral to us. If it was to go away, I think it would be neutral to us. It might be a slight negative, but it might also be a slight opportunity for us to work through the issues and meet the demand. And I think all of our facilities are positioned well to meet this issue.
我們認為這件事的曝險,不論正面或負面,都非常小,但我們還是得觀察後續發展。每個人都希望能取得心理健康(mental health)福利,這點大家都有共識。至於在更改醫療法的過程中——如果這件事可行、而且他們有足夠票數能推動——我們只能拭目以待。但對我們服務的需求,以及雇主與各州政府,都了解為這些個人及其家庭提供保障的重要性,所以——正如我們在 ACA 剛上路時所說,對我們而言更偏中性。如果它真的取消,我認為對我們也會是中性。可能會有些微負面,但也可能是些微的機會,讓我們去處理相關議題並滿足需求。我認為我們所有設施都已做好準備來應對這個議題。
Unidentified Analyst
Unidentified Analyst
All right. Got it. And then just going back to your comment on organic growth, Q1, obviously, usually the weakest, but as I look at the last 3 quarters, you guys have reported somewhere in the 6% range, effectively for the U.S. So how do you view organic growth ramping up beginning in the second quarter, given the number of beds you've added? Is that a good way to think about that, just looking back the number of beds, especially the percentage of that in the U.S. and also how IMD plays into that whole equation?
好。了解。再回到你對內生成長(organic growth)的評論:第一季通常最弱,但我看你們過去三個季度在美國大概都報告了約 6% 左右。那麼在你們新增床位數的情況下,你如何看待從第二季開始內生成長的拉升?用這種方式思考是否合理——回頭看新增床位數,尤其是美國的占比,以及 IMD 在整個方程式中扮演的角色?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Okay. Obviously, when you look at the U.S. same-facility patient day growth, the actual number's 5.8%. That's up against a tough comp and up against an extra day last year. So if you adjust for those 2 factors, patient day growth actually was about 6.9% for the first quarter. So that is trending better than what we saw in the last 2 quarters, I think of last year. Just -- now this is what is today, April 26, this was the first 26 days here in the U.S. in April. We're above 6% and on the same-store growth again this time, with more beds in line -- online. So we're still very optimistic about our ability to grow the patient days and so we feel good about that, Ron Fincher and his operations team and the people that support the growth in our facilities and bringing the beds online, they're doing an outstanding job, and we expect that to continue for the rest of the year and -- but the first quarter was a tough comp period, even with the leap year day.
好的。顯然,當你看美國同院(same-facility)的病患日(patient day)成長,實際數字是 5.8%。這是面對一個很高的比較基期(tough comp),而且去年還多了一天。所以如果把這兩個因素調整掉,第一季的病患日成長其實大約是 6.9%。因此,這個趨勢比我記得去年最後兩季看到的還要好。另外——以今天 4 月 26 日來看,這是美國 4 月前 26 天的表現。我們同店成長再次高於 6%,而且這次還有更多床位陸續上線(online)。所以我們仍然對提升病患日的能力非常樂觀,也因此感覺良好。Ron Fincher 和他的營運團隊,以及支持我們在各設施推動成長、讓床位上線的人員,都做得非常出色;我們預期這種表現會在今年剩餘時間持續下去——但第一季確實是個比較基期很硬的期間,即使包含閏年多出的一天也是如此。
Unidentified Analyst
Unidentified Analyst
And joint IMD, just if you don't mind just tying that in there. What are your thoughts there?
還有關於聯合 IMD,如果你不介意把這點也一起帶進來。你對那方面有什麼看法?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
I'm looking at Brent. He's our IMD expert.
我在看 Brent。他是我們的 IMD 專家。
William Brent Turner - President
William Brent Turner - President
Again, I think with a lot of the noise around the ACA, repeal and replace, we probably didn't see any significant change in our Medicaid exposure during the first quarter compared to the sequential fourth quarter. But again, the trend is there, the IMD waiver for the managed Medicaid plans, that is not change -- that did not have any connection back to the ACA issue. So again, we're very optimistic about more access for patients including Medicaid going forward. But we didn't see a big sequential impact on our Medicaid volumes in the first quarter.
再說一次,我認為圍繞 ACA 的各種雜音、廢除與取代,我們在第一季相較於前一季第四季,在 Medicaid 曝險上大概沒有看到任何顯著變化。但同樣地,趨勢是存在的:針對管理式 Medicaid 計畫的 IMD 豁免,這並沒有改變——而且那與 ACA 議題沒有任何關聯。所以我們對未來(包含 Medicaid 在內)病患能獲得更多就醫可近性仍然非常樂觀。但我們在第一季的 Medicaid 量並沒有看到很大的季對季影響。
Operator
Operator
And our next question will come from (inaudible) from (inaudible)
下一個問題來自(聽不清)自(聽不清)。
Unidentified Analyst
Unidentified Analyst
The question I had was on the pricing growth, which looks weak. It's flat to down. I was wondering how much of that is Medicaid mix shifting relative to -- are you seeing any pressure at all to your commercial contract as far as rates go?
我想問的是定價成長,看起來偏弱。幾乎持平到下滑。我想知道其中有多少是 Medicaid 組合占比變動所致——相較於……你們在商業保險合約的費率方面,有看到任何壓力嗎?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
The rate environment is similar to what it's always been, [ Ana ]. Medicaid, as Brent mentioned earlier, was -- is flat when you look at it for us. Our Medicaid utilization, there was not the big shift there. The commercial payers, it's still in a negotiation process, and we go through those, wanting to get an increase between 4% to 6%. Naturally, they're wanting to pay less. But anyway, this is a process that we go through. And many times, because of the -- due to the size of our company now and the beds and with the U.K. being a part of it, the mix of the patient can impact that to some extent. And so we have seen some real positive growth in some of our child and adolescent residential programs. So you have to take all those factors. Obviously, we would like it a little bit higher and we negotiated contract by contract. We don't have a national contract, so we're working there. And I think our outpatient revenues will get stronger throughout the year. And I think that will also help add to the revenue per day calculation.
費率環境跟以往差不多,[ Ana ]。如 Brent 先前提到的,Medicaid——就我們來看——是持平的。我們的 Medicaid 使用量沒有出現很大的轉移。商業保險方仍在談判流程中,我們在那些談判裡,希望能拿到 4% 到 6% 的調升。當然,他們希望付得更少。但不管怎樣,這就是我們一貫會走的流程。而且很多時候,由於——因為我們公司現在的規模、床位數,以及英國業務也納入其中,病患組合在某種程度上會影響這點。因此,我們在部分兒童與青少年住宿式方案上看到相當正面的成長。所以你必須把所有這些因素都納入考量。顯然,我們希望能再高一點,我們是一份合約一份合約地談。我們沒有全國性合約,所以我們正在那方面努力。而且我認為我們的門診營收會在今年逐步轉強。我也認為那將有助於提升每床日營收的計算。
Ana Gupte - MD, Healthcare Services and Senior Research Analyst
Ana Gupte - MD, Healthcare Services and Senior Research Analyst
Okay. That's helpful. Just one follow-up on us again on the revenue side, your volumes are very strong and you gave us some color, but -- and in the patient days look good, but it's lagging the volume and I was wondering if there's any pressure on length of stay and are you doing that activity because of mix shifting to acute from residential or watching the regulatory environment or something else?
好的。這很有幫助。再追問一個關於營收端的問題:你們的量非常強,你們也提供了一些說明,但——病患日數看起來也不錯,可是它落後於量的成長;我想知道住院天數是否有任何壓力?以及你們是否因為組合從住宿式轉向急性、或是在觀察監管環境、或其他原因而進行那樣的動作?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Well, you know,[ Ana ], we have built mainly acute beds, and so that would naturally lower the length of stay to some extent. But we don't see a lot of pressure on the length of stay that -- actually, length of stay is pretty stable and it's just a mix of patients that we have on any given quarter that determine that and -- but we are building more acute beds and this year's bed build will be more acute oriented also.
嗯,你知道的,[ Ana ],我們主要建的是急性床位,所以那自然會在某種程度上拉低平均住院天數。但我們沒有看到住院天數有很大的壓力——事實上,住院天數相當穩定;主要是每一季我們所接收的病患組合決定了它——而且……但我們正在建更多急性床位,今年的增床也會更偏向急性。
Operator
Operator
And our next question comes from Frank Morgan from RBC Capital Markets.
下一個問題來自 RBC Capital Markets 的 Frank Morgan。
Frank G. Morgan - MD
Frank G. Morgan - MD
I know there's obviously been a challenging 12 months, a lot of work underway. And now that you have a lot of these issues behind you, when you think about where you are operationally and from a financial perspective, I know you've got that capital to deploy, but are you really -- do you feel like you're any rush to it really go out and take on another large acquisition?
我知道過去 12 個月顯然相當具挑戰性,也有很多工作正在進行。現在你們已經把不少問題拋在身後,當你從營運與財務角度思考目前的位置時,我知道你們有資本可以部署,但你們真的——你們覺得有任何急迫性要出去再做一筆大型併購嗎?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
We're absolutely in no rush, and that's reason, I guess, I kind of cautioned a little bit, I think when A.J. asked the question about large transactions. You know, we may have turned up our due diligence and made it even a little bit stronger than what it had been in the past. So we want to make the right acquisition. The acquisition won't -- obviously, the large one would be here in the U.S. and so -- but we're in no rush to do that. And we have plenty of things to take care of and there will be plenty of joint venture opportunities and -- to do this year and next year. So we're positioned very well to add growth to this company but add good growth to this company and so -- and give our operations team credit here in the U.S. and in the U.K. The Priory transaction was a large transaction. And even though we had issues with the CMA, our team on board right now and the work they've already done has been outstanding, and we only see better and positive -- more positive things happening for us there.
我們完全不急,我想這也是我在 A.J. 問到大型交易時稍微提醒一下的原因。你知道,我們可能把盡職調查做得更深入,甚至比過去更嚴謹一些。所以我們想做對的收購。收購——顯然,大型的會在美國這邊——所以……但我們不急著做。而且我們有很多事情要處理,今年和明年也會有很多合資機會——可以去做。所以我們的定位非常好,能為公司增加成長,但要增加的是高品質的成長;因此——也要肯定我們在美國與英國的營運團隊。Priory 交易是一筆大型交易。即便我們在 CMA 上遇到一些問題,但我們目前的團隊以及他們已經完成的工作都非常出色,我們只會看到更好、更正面的——更多正面的事情在那邊發生。
Frank G. Morgan - MD
Frank G. Morgan - MD
Got you. And then speaking of the U.K., I think you talked about seasonality and things getting stronger after that difficult first quarter. Is that the same trend in the U.K? Does that follow the same trend in the U.S.? Seasonality?
了解。那談到英國,我想你提到季節性,以及在艱難的第一季之後會轉強。英國也是同樣的趨勢嗎?它跟美國一樣嗎?季節性?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
To somewhat, but they have more -- they're probably listening. They have a few more holidays than we do, so we have -- we're getting used to their holiday schedule or their vacation schedule and the European way of relaxing and taking time off. I know the -- as you know, they've triggered the divorce with the European Union or the Brexit. So there's a little uncertainty there. So -- but the pound has reacted nicely, both to what's happening in the U.S. and what's happening in the U.K.. So we'll just have to wait and see. We have lots of work to do there and plenty of opportunities, and our guys are doing it.
某種程度上是,但他們有更多——他們可能正在聽。他們的假期比我們多一些,所以我們——正在適應他們的假期安排或休假安排,以及歐洲那種放鬆、休息的方式。
Frank G. Morgan - MD
Frank G. Morgan - MD
And just the last question, on a relative base, the weaker volume growth in the U.K., I know you talked about a shortage of nurses there, do you attribute it to that? Or is there any other issue that you would call out for that weaker relative performance?
最後一個問題:以相對基期來看,英國的量成長較弱;我知道你提到那邊護理人員短缺,你把它歸因於這點嗎?還是有其他你會點出的因素,導致相對表現較弱?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Not so much the nurses. We can use agency nurses to take care of the patients, and that's more of a common practice over there than it is here in the U.S. I think the British government is a little bit more cautious, and more cautious meaning that NHS is more cautious. So I think there's a little -- this Brexit thing, I think they're just looking and watching and seeing and see how they feel good and see what happens to their economy. And so -- which is okay, for us. We have plenty of opportunity. We have plenty of beds we can fill. And we will -- I think, you will see us -- maybe our private mix will probably grow some. I think it's about 5% of our patient days now over there, and patient -- private mix could grow.
不完全是護理人員的問題。我們可以使用派遣護理人員(agency nurses)來照護病患,而那在英國比在美國更常見。我認為英國政府比較謹慎,而所謂更謹慎是指 NHS 更謹慎。所以我覺得有一點——這個 Brexit 的事情,我想他們只是觀望、看一看,看看他們覺得是否安心,以及他們的經濟會怎麼走。所以——對我們來說也沒問題。我們有很多機會。我們有很多床位可以填滿。而且我們會——我想你會看到我們——也許我們的自費(private)組合占比可能會成長一些。我想目前那邊自費大約占我們病患日數的 5%,而病患——自費組合可能會成長。
Operator
Operator
Our next question (inaudible)
我們的下一個問題(聽不清)
Unidentified Analyst
Unidentified Analyst
Just wanted to get an update on the de novos that you opened last year. I guess, they were a little bit of a drag in Q2 and Q3. Sounds like they were getting better in Q4. Was there any drag in the quarter from those ramping up?
只是想請您更新一下去年開設的那些新設據點(de novo)的情況。我想,它們在第二季和第三季對業績有些拖累。聽起來第四季有在改善。本季這些據點在爬坡期是否仍帶來任何拖累?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Well, there's always a drag until they get to our margin. But I'm pleased to report that group is positive earnings and quite -- and Kevin, of those four that we mentioned last year, in the next 90 days, we'll probably be doing expansion plans for them, that these (inaudible) during the last 90 days, since the 1st of the year has been outstanding at these 4 de novos, and they still have some more room to grow into their existing capacity. But as you know, we plan ahead and I see all 4 of these facilities that we could start today planning to build them more beds. And so but they're not at the 25% margin yet, but you know, they'll be growing into that. But the main thing was getting them out of the red and getting them cash flow positive and earnings positive, and that's what we've done.
嗯,在它們達到我們的利潤率之前,總是會有一些拖累。但我很高興可以報告,那一組已經是獲利為正,而且相當——Kevin,就我們去年提到的那四家而言,在接下來 90 天內,我們可能會為它們做擴建計畫;因為這些(聽不清)在過去 90 天、也就是自今年年初以來,這 4 個新設據點的表現非常出色,而且它們在既有產能下仍有一些成長空間。但如你所知,我們會提前規劃;我看到這 4 個設施其實今天就可以開始規劃再增加床位。所以它們還沒到 25% 的利潤率,但你知道,它們會逐步成長到那個水準。但最重要的是讓它們脫離虧損、讓現金流轉正、盈餘轉正,而這就是我們已經做到的。
Unidentified Analyst
Unidentified Analyst
Again, how do we think about those 3 de novos that you opened up this year? Is there a drag from those 3 in the guidance? Should that change kind of the progression or seasonality at all as we think about the last 3 quarters?
再問一次,我們該如何看待今年新開的那 3 個新設據點(de novo)?指引中是否包含這 3 個據點帶來的拖累?在我們思考接下來 3 個季度時,這會不會改變成長進程或季節性?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Should not. That was taken care of inside our budget. That should not. We factored that in to our guidance.
不會。這部分已經在我們的預算內處理好了。不會的。我們已把它納入指引考量。
Unidentified Analyst
Unidentified Analyst
I guess it was in the guidance, I am just trying to think about how we should be modeling it. Is it -- heavily weighted --
我知道它已經在指引裡了,我只是想想我們建模時應該怎麼處理。它是否——權重會很偏向——
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Obviously, during the first 90 days, they lose money. And it's just how quickly we go after that. Now one of these joint ventures is with a partner that, that facility could fill up quickly. So that might be a different story on the largest facility that we're doing, the de novo facility that we're doing this year that we have on an unbelievable partner with us, joint venture partner. But we'll just have to wait and see. We've already hired the CEO for that facility, and it doesn't open until the end of the third quarter, first of the fourth quarter and we already hired the CEO, and we're getting ready for that to do the best we can do -- but these 3 de novos this year are all second half of this year transactions.
很明顯,在前 90 天它們會虧錢。接下來就是看我們能多快把它們拉上來。其中一個合資案是和一個合作夥伴一起做,那個設施可能很快就能滿床。所以在我們今年做的最大那個設施——今年要做的新設(de novo)設施——情況可能會不一樣,因為我們有一個非常出色的合作夥伴作為合資夥伴。但我們只能拭目以待。我們已經為那個設施聘用了 CEO,而它要到第三季末、第四季初才會開幕;我們已經先聘了 CEO,並且正在做準備,盡我們所能做到最好——但今年這 3 個新設據點的交易都會在今年下半年發生。
Operator
Operator
(inaudible)
(聽不清)
Unidentified Analyst
Unidentified Analyst
Of the 800 beds you're adding this year, can you just remind us how many of those bed additions are to existing facilities versus joint ventures or de novos, and maybe just remind us, the cadence of how those beds are coming online over the course of the year?
今年你們要新增的 800 張床位中,可以提醒我們其中有多少是既有設施的擴增、多少是合資或新設(de novo)嗎?另外也請再提醒一下,這些床位在一年當中上線的節奏大概是怎樣?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Okay. Let me give you how we have them coming online. We have -- we did 82 in the first quarter and we thought we'd do in the 70s. We'll do in the 70s probably in the second quarter. We'll do about 250 beds in the third quarter and close to 400 beds in the fourth quarter, with the large de novo project coming online in the fourth quarter. David, do you know how many beds there are in the de novos?
好的。我先說明我們讓它們上線的節奏。第一季我們做了 82 張,我們原本以為會在 70 多張。第二季我們大概也會做 70 多張。第三季我們會做大約 250 張床位,第四季接近 400 張床位,其中大型的新設(de novo)專案會在第四季上線。David,你知道新設據點(de novo)有多少床位嗎?
David M. Duckworth - CFO, CAO and Controller
David M. Duckworth - CFO, CAO and Controller
Yes. With -- of the 800 beds, about 225 of those would be the de novo beds.
知道。在這 800 張床位中,大約 225 張會是新設(de novo)床位。
Unidentified Analyst
Unidentified Analyst
Got it. David, is there still a number to think about for CapEx this year?
了解。David,今年資本支出(CapEx)還有一個可以參考的數字嗎?
David M. Duckworth - CFO, CAO and Controller
David M. Duckworth - CFO, CAO and Controller
Yes, we had not changed our CapEx projection for the year. With the timing of it, it was a little bit lower in the first quarter, but we think, as you look at the course of the year, not an individual quarter, we still hold to our expectation. Around 2.7% of revenue would be the maintenance. And for this quarter, expansion CapEx was around $35 million of the total CapEx, and we see that number just with the timing of the beds and the spend this year, we see that number moving back to the norm over the last 9 months of the year, should be above $50 million or so a quarter.
有的,我們沒有調整今年的資本支出(CapEx)預估。就時點而言,第一季稍微低一些,但我們認為如果你看的是全年而不是單一季度,我們仍維持原先的預期。維護性支出約為營收的 2.7%。而本季擴張性資本支出約為 3,500 萬美元(占總 CapEx 的一部分);我們認為隨著今年床位上線與支出時點的安排,接下來 9 個月這個數字會回到常態,每季應該會在 5,000 萬美元以上左右。
Unidentified Analyst
Unidentified Analyst
Great. And you may or may not have this at your fingertips, David, bus is there any way to provide us what the U.K. revenue and EBITDA was in the second quarter of last year after accounting for the divestitures? Just trying to make sure that we all have the right jumping off point as we think about the year-over-year growth.
很好。David,你可能手邊有也可能沒有:在扣除資產剝離(divestitures)之後,能否提供去年第二季英國(U.K.)的營收與 EBITDA 是多少?只是想確保我們在思考年對年成長時,起算基準點是正確的。
David M. Duckworth - CFO, CAO and Controller
David M. Duckworth - CFO, CAO and Controller
I will follow-up with you on that one. We'll discuss that.
我會再跟你補充那一題。我們再討論。
Operator
Operator
(inaudible)
(聽不清)
Unidentified Analyst
Unidentified Analyst
In the past, you've talked about needing to do JVs with hospitals and other types of arrangements in order to garner some of the benefit from the changes in the IMD exclusion. Can you just update us on how that's going?
過去你們談到,為了從 IMD 排除條款變更中取得部分效益,需要與醫院做合資(JV)以及其他類型的安排。可以更新一下目前進展如何嗎?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Again, I think from Acadia's perspective, the opportunity with the joint ventures is really entering markets that we would otherwise not have an opportunity to go into. And what we've seen is tremendous reception from these not-for-profit, principally health systems, welcoming us to come in and be the lead on this psychiatric facility. The IMD may be a corresponding impact, the expansion of the IMD, but the real driver is the recognition that there's huge demand, huge needs in these markets and the medical surgical providers, it's just not their focus. And so they're absolutely saying, Acadia, come help us solve this and let's share in the upside. As Joey mentioned, we expect the ramp to be quicker. And because of that they get the -- they're going to be participating in the ownership a little bit with us. Again, I think just to state it a little more clearly, is -- this is a growth avenue for us. It's next year, it's the following year, the deals are getting signed now and this is just as impactful as M&A. So when people ask about the big deals, they shouldn't lose sight of the messaging that we're signing joint ventures very actively, which will really be helpful for the long-term value of the Acadia enterprise.
再說一次,我認為從 Acadia 的角度來看,合資(joint ventures)的機會主要在於進入一些我們原本沒有機會進入的市場。而我們看到的是,這些非營利機構——主要是醫療體系——對我們的加入反應非常熱烈,歡迎我們進來並在這家精神科設施中擔任主導角色。IMD 可能會帶來相應影響,也就是 IMD 的擴大,但真正的驅動因素是大家認知到這些市場有巨大的需求、巨大的缺口,而內外科醫療提供者並不把這當作他們的重點。所以他們非常明確地說:Acadia,來幫我們解決這個問題,並且讓我們一起分享上行空間。如 Joey 提到的,我們預期爬坡會更快。也因為如此,他們會在所有權上與我們共同參與一些。再更清楚地說——這是我們的一條成長途徑。不只是明年、後年;交易現在就正在簽約,而其影響力不亞於併購(M&A)。所以當大家問到大型交易時,不應忽略我們的訊息:我們正在非常積極地簽合資案,這將對 Acadia 企業的長期價值非常有幫助。
Unidentified Analyst
Unidentified Analyst
Can you give us any idea of how many you expect to sign this year or how many you're talking to or potentially in the pipeline?
你能否讓我們大概了解一下,今年預期會簽多少個?或你們正在洽談多少個、潛在管線中有多少個?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
There's approximately 20 on the pipeline. The other information is a little bit confidential at this time.
管線中大約有 20 個。其他資訊目前有點機密。
Unidentified Analyst
Unidentified Analyst
And you think most of those 20 (inaudible) signed this year?
而你認為今年簽下的那 20 個(聽不清)大多數都會在今年完成嗎?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
No, we won't sign 20 this year. But there's plenty for us to do. But we don't want to tip our hand here other than there's about 20 on the pipeline.
不,我們今年不會簽 20 個。但我們還有很多事情要做。不過我們不想在這裡透露太多,只能說管線上大約有 20 個。
Unidentified Analyst
Unidentified Analyst
Got it. And then maybe could you update us on your -- how CRC's doing and maybe what the impact of any increased funding for the opioid epidemic, how that's benefiting you?
了解。另外,你能否更新一下你們——CRC 的表現如何,以及針對阿片類藥物疫情若有任何增加的資金投入,對你們有什麼影響、如何讓你們受益?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
The opiate money and the Cures Act, it will be some more months before we see how that actually trickles out. And gets to the opiate -- how they will use that to address the opiate addition -- addiction issue. That's a non-factor for us right now. We're glad that they've set aside the money and they're talking about it. But right now, it's a state-by-state opportunity for us. And like for example, I think of the Cures Act, I think [ Timothy ] is getting like 10 -- $13 million. Now $13 million is a lot of money, but then on the other hand, it's not a lot of money. So we'll just have to wait to see how the governor wants to use that money to help on the opiate addiction issue. So all of our state are aware of this, and we got a lot of activity there. Brian [ Kegey ], who heads up our special projects government relations, he has this as an opportunity for him.
阿片類資金以及《Cures Act》(治癒法案),還需要再過幾個月我們才會看到資金實際如何逐步下放。以及他們會如何運用這些資金來處理阿片類——他們將如何用它來解決阿片類成癮——成癮問題。目前對我們來說還不是影響因素。我們很高興他們撥出了這筆錢,也在討論這件事。但就目前而言,對我們來說是逐州而定的機會。例如,談到《Cures Act》,我想到 [ Timothy ] 會拿到大概 10——1,300 萬美元。1,300 萬美元是一大筆錢,但另一方面,也不算很多。所以我們只能等著看州長想如何運用這筆錢來協助解決阿片類成癮問題。因此我們所有的州都知道這件事,我們那邊也有很多活動在進行。負責我們特殊專案政府關係的 Brian [ Kegey ],他把這視為他的機會。
Operator
Operator
Our next question will come from Ann Hynes from Mizuho Securities.
下一個問題來自瑞穗證券(Mizuho Securities)的 Ann Hynes。
Ann K. Hynes - Senior Healthcare Services Analyst
Ann K. Hynes - Senior Healthcare Services Analyst
So I have 2 follow-up questions, that I guess I need more clarity on, one on your U.S. same-store margin decline. Why is that down year-over-year? Is it just because you have a tough comp with Q1? I know same-store revenue is very strong last year. Is it incremental labor issues? Is it length of stay? I just want more detail on that, that will be great.
我有兩個追問,我想我需要更清楚一些,其中一個是關於你們美國同店毛利率下滑。為什麼年對年會下降?只是因為第一季的比較基期很高嗎?我知道去年同店營收非常強勁。是新增的人力成本問題嗎?是住院天數(length of stay)嗎?我想要更多細節,如果可以的話會很棒。
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Okay, it was a tough comp. Obviously, it was a tough comp. The one day also impacts this. We could've gotten a little bit more on the revenue side. I think we could've done a little bit better on the revenue, and most of that would have -- flowed to the bottom line. But we're very pleased with the first quarter results, you know. We thought we would make $0.46 and that's what we did. But the margin was up against a tough comp, and then we could have a little bit more revenue than what we had. But we'll take it. It's a great quarter. A lot of operations worked very hard and a lot of things positive. So -- but that's the primary 2 reasons for the margin.
好的,確實是比較基期很高。很明顯,是個很高的比較基期。多出來的那一天也會影響這個數字。我們在營收端本來可以再多拿到一點。我認為我們在營收上可以做得更好一些,而其中大部分本來會——流到淨利。但我們對第一季的結果非常滿意,你知道的。我們原本預期每股盈餘會是 0.46 美元,而我們也做到了。但毛利率面臨高基期的壓力,另外我們的營收也可以比實際更高一些。不過我們接受這個結果。這是一個很棒的季度。很多營運團隊非常努力,很多事情都很正面。所以——但毛利率主要就是這兩個原因。
Ann K. Hynes - Senior Healthcare Services Analyst
Ann K. Hynes - Senior Healthcare Services Analyst
Okay. Perfect. And also getting back to the U.K. market, I know, I guess, this is the first time I've heard you say that maybe Brexit is impacting results, albeit modestly. How would you view -- is it impacting emissions? Is it NIH being more conservative with reimbursement or outsourcing of beds? Or how has it directly impacting you, do you think?
好的。完美。另外回到英國市場,我想,這是我第一次聽到你說脫歐可能正在影響結果,雖然影響不大。你會怎麼看——它是在影響入院(admissions)嗎?是 NHS 在給付或外包床位方面變得更保守嗎?或者你認為它是如何直接影響你們的?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Well, it doesn't impact us directly. It's more the Brexit and the government over there working through that process. And I think they are a little bit more conservative today until they get through that process and see how it shakes out. But it appears to be there's a silver lining here that the NHS is pushing more of the contracting and placing of patients to the local authority, which is closer -- which would be the authority near our facility. And so from that, we have been seeing better rate increases and access to patients. So there are some positives there. But in a whole, the British government and I think everyone over there is just kind of waiting and seeing a little bit more about how does the Brexit, how's this all going to work and the implications there. But there are some positive signs too that I just didn't mention. But we believe the local authorities are going to have more influence on placing their patients and negotiating their rates.
嗯,它不會直接影響我們。更多是脫歐以及那邊政府正在推進這個流程。我認為在他們走完這個流程、看清楚結果之前,現在會稍微更保守一些。但看起來有個好處是,NHS 正在把更多的簽約與病患安置推向地方政府(local authority),而那個單位更接近——也就是靠近我們機構所在地的主管機關。因此,我們看到更好的費率調升以及更容易接觸到病患。所以確實有一些正面因素。但整體而言,英國政府以及我想那邊的每個人,都還在觀望脫歐到底會怎麼運作,以及其影響。不過也有一些正面跡象我剛才沒有提到。但我們相信地方政府在安置其病患以及協商費率方面,將會有更大的影響力。
Ann K. Hynes - Senior Healthcare Services Analyst
Ann K. Hynes - Senior Healthcare Services Analyst
Okay, that's helpful. And just one last thing about the U.K., because I know with the divestitures, can you describe the assets that you were left with? Because I know there's the slower growth, I think you said on the last quarter conference call, maybe the same-store growth profile is more like 4% to 5% because those are more adult services. So can you just maybe reiterate if I'm correct way that, that we're all in line with the same-store growth over in the U.K? And secondly, obviously, Q1, we expect -- should we expect a ramp up in same-store growth in the U.K. How we're thinking about it within guidance?
好的,這很有幫助。關於英國我最後還有一點,因為我知道你們做了資產剝離,你能描述一下你們剩下的資產是什麼樣子嗎?因為我知道成長較慢,我想你在上一季電話會議上說過,同店成長輪廓可能更像 4% 到 5%,因為那些更多是成人服務。所以你能否再重申一下我這樣理解是否正確,讓我們對英國同店成長的看法一致?第二,顯然第一季,我們預期——我們是否應該預期英國同店成長會逐步加速?在指引範圍內我們該如何看待?
David M. Duckworth - CFO, CAO and Controller
David M. Duckworth - CFO, CAO and Controller
Ann, this is David. And just starting what the company looks like now in the U.K., you are right. The divestiture was within our healthcare division. So we did see the education, adult care and the elderly care division become a little bit more significant to the total. We should see strong growth across all of those divisions, but we do have healthcare, education and adult that are growing a little bit faster than the elderly care division. So that is the mix change that we should see. But after the divestiture healthcare, education and adult care continue to be our strongest division. And we do think that over the course of the year, as the integration is completed that we should see the growth pickup in the U.K. .
Ann,我是 David。先從公司現在在英國的樣貌談起,你說得沒錯。這次資產剝離是在我們的醫療保健事業部內。因此,我們看到教育、成人照護以及高齡照護事業部在整體中的比重變得更顯著。我們應該會看到這些事業部都維持強勁成長,但醫療保健、教育與成人照護的成長速度會比高齡照護事業部更快一些。所以這就是我們預期會看到的組合變化。但在資產剝離之後,醫療保健、教育與成人照護仍然是我們最強的事業部。而且我們確實認為,隨著整合在一年內完成,英國的成長應該會回升。
Operator
Operator
We'll take our next question from Chris Rigg from Deutsche Bank.
我們下一個問題來自德意志銀行(Deutsche Bank)的 Chris Rigg。
Christian Douglas Rigg - Research Analyst
Christian Douglas Rigg - Research Analyst
Joey, you mentioned a couple of statistics on the impact of the leap year. I think you said 150 basis points to same-store U.S. revenue and about 110 to patient days. Can you confirm that, that is correct? And was there any impact in the U.K?
Joey,你提到幾個關於閏年影響的統計數字。我想你說同店美國營收影響約 150 個基點,病患日數約 110 個基點。你能確認這樣是正確的嗎?另外英國那邊有任何影響嗎?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Okay, it's 110 for both of those, not 150. It's 110 here in the U.S. In the U.K., it was between -- because we bought it partway through the quarter, you know, it's more like a 70 basis point improvement -- adjustment there.
好的,兩個都是 110,不是 150。在美國這邊是 110。在英國,因為——我們是在該季度中途才買下來的,你知道的,所以更像是 70 個基點的改善——那邊的調整大概是這樣。
Christian Douglas Rigg - Research Analyst
Christian Douglas Rigg - Research Analyst
Okay. Okay.
好的。好的。
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Where it's 110 here.
這裡是 110。
Christian Douglas Rigg - Research Analyst
Christian Douglas Rigg - Research Analyst
Got it. Got it. Just on the -- you made broad comments about, I would just call it, occupancy in de novos, but when you think about the organic bed development, how quickly than those beds normally get to sort of company level occupancy when you bring them on?
了解。了解。就你剛才提到的一些較為概括的評論,我姑且稱之為新設機構(de novos)的入住率;但當你們思考有機床位擴增時,這些床位在啟用後,通常需要多快才能達到大致公司層級的入住率?
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
We won't -- those beds, we would want to come to our occupancy within 2 years. At the end of 24 months, the new beds added to existing facilities would be at the occupancy after 24 months.
我們不會——那些床位,我們希望在 2 年內達到我們的入住率水準。在 24 個月結束時,新增到既有設施的新床位,會在 24 個月後達到相應的入住率。
Christian Douglas Rigg - Research Analyst
Christian Douglas Rigg - Research Analyst
Okay. And then on cash -- operating cash flow for the year, I apologize again if I missed it, but can you give us a sense where you think that will shake out?
好的。那再談現金——本年度的營運現金流,我再次抱歉如果我漏聽了,但你能否讓我們了解一下你認為最後會落在什麼水準?
David M. Duckworth - CFO, CAO and Controller
David M. Duckworth - CFO, CAO and Controller
Yes. I think for the year, we should be in the $400 million range. The first quarter is always the lowest quarter just with the seasonality that we see as well as the working capital needs and interest payment, things like that, that we see in the first quarter. But the full year number should be strong at around $400 million.
可以。我認為全年應該會在 4 億美元左右。第一季一向是最低的一季,主要因為我們看到的季節性因素,以及營運資金需求與利息支付等,這些都會在第一季出現。但全年數字應該會很強勁,大約在 4 億美元左右。
Christian Douglas Rigg - Research Analyst
Christian Douglas Rigg - Research Analyst
Okay. And then so with even the expansionary CapEx, do think that the $400 million will be sufficient to cover the 800 beds coming -- cover everything, let's call it that?
好的。那麼即使包含擴張性的資本支出(CapEx),你認為這 4 億美元足以涵蓋即將新增的 800 張床位——也就是涵蓋所有支出,我們就這麼說吧?
David M. Duckworth - CFO, CAO and Controller
David M. Duckworth - CFO, CAO and Controller
Yes. It will be more than sufficient. We should have excess cash flows after we fund those projects.
是的。這會綽綽有餘。在我們為這些專案提供資金之後,仍應該會有多餘的現金流。
Operator
Operator
We'll take our next question from (inaudible)
我們將接聽下一個問題,來自(聽不清)。
Unidentified Analyst
Unidentified Analyst
David, I just want to make sure I heard you clearly. On same-store revenue in the press release, you guys reported 4.8% growth, but did I hear you say that constant currency, it would be 5.6%? Is that right?
David,我只是想確認我聽得沒錯。在新聞稿中,你們公布的同店營收成長是 4.8%,但我是否聽到你說若以固定匯率計算會是 5.6%?是這樣嗎?
David M. Duckworth - CFO, CAO and Controller
David M. Duckworth - CFO, CAO and Controller
You know, I don't know if we gave a constant currency stat on the same-store line. The same-facility numbers that we presented in the press release are already adjusted for constant currency, that you would not to make an additional adjustment if you're looking at our same-facility presentation.
你知道,我不確定我們是否在同店那一行提供了固定匯率的數據。我們在新聞稿中呈現的同設施(same-facility)數字已經做了固定匯率調整,所以如果你看的是我們的同設施呈現方式,就不需要再做額外調整。
Unidentified Analyst
Unidentified Analyst
Okay, great. And then Joey, on length of stay in the U.K., it was down 11% year-over-year, and I just want to make sure I understand that -- your explanation you said earlier. Did you say it was -- you had more of the hospital side, you had growth there, which brought down the length of stay. Just wanting to understand that a little bit better.
好的,很好。接著 Joey,英國的平均住院天數(length of stay)年減 11%,我只是想確認我理解你先前的說明——你是說醫院端的比重較高、那邊有成長,因此拉低了平均住院天數?我想更清楚理解一下。
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Hey, Charles, really when you look at the U.K., you've got a complete mix shift going on within the same facility within the first quarter and only for a portion of the first quarter. So it's really hard to triangulate exactly what's -- there's nothing "going on there," other than the effect of the adult division, the education division and the elderly care division rolling into the same facility, but only for a portion of the quarter. I think we've mentioned before, the U.K. stats I going to have to -- let them mature into the presentation before you can really fully anticipate the trends from that segment.
嗨,Charles,其實當你看英國時,你會發現第一季在同一設施內發生了完整的組合轉移(mix shift),而且只涵蓋第一季的一部分期間。所以很難精確地交叉驗證到底發生了什麼——那裡並沒有什麼「正在發生」的特殊狀況,除了成人事業部、教育事業部與高齡照護事業部併入同一設施所帶來的影響,但也只反映了該季的一部分。我想我們之前提過,英國的統計數據需要——讓它們在呈現方式中逐步成熟之後,你才能真正充分預期該區隔的趨勢。
Unidentified Analyst
Unidentified Analyst
Okay, that makes sense. Thanks, Brent. And then last question for me on guidance. You set guidance at $1.28 on U.K. pound. And right now, we're at a $1.28. So why would you not raise the guidance modestly? Is it just conservatism? Or is there some other factors going on here?
好的,這樣就說得通了。謝謝,Brent。那我最後一個問題是關於財測指引。你們把英鎊匯率假設設在 1.28 美元。而現在我們就在 1.28。那為什麼不小幅上調指引呢?只是出於保守嗎?還是還有其他因素?
William Brent Turner - President
William Brent Turner - President
It's just -- the $1.25 is absolutely the rate that we based it on for the year. And while we're optimistic about some of the Brexit and the election proposal helping boost the value of the pound, we can't say with certainty it's going to stay at $1.28. So I think the absolute fact is if it's at $1.28, our earnings will be higher than it if it was at $1.25, so we'll adjust that on a real-time basis. So we didn't have a lot of clamoring to move it to $1.22 last year when it went below $1.25. So we've got to realize the effect of that. And if it's at $1.28 or $1.30, that's great. We just can't absolutely have confidence is going to stay at that level for the year. So from a consistency standpoint, we'll just hold at $1.25 and adjust accordingly however the pound trends over the next 3 quarters.
就是——1.25 美元這個匯率,確實是我們用來作為全年基礎假設的匯率。雖然我們對某些脫歐進展以及選舉提案可能有助於推升英鎊價值感到樂觀,但我們無法確定它會維持在 1.28 美元。所以事實上,如果匯率在 1.28 美元,我們的獲利會高於以 1.25 美元計算的情況,因此我們會即時調整其影響。同樣地,去年當英鎊跌破 1.25 美元時,也沒有很多人強烈要求我們把它改到 1.22。所以我們必須認知到這個影響。如果在 1.28 或 1.30,那很好。只是我們無法百分之百有信心它全年都會維持在那個水準。因此,基於一致性,我們就維持 1.25,並依未來 3 個季度英鎊走勢來相應調整。
Operator
Operator
And we have no further questions at this time. I'd like to turn the conference back of store Mr. Jacobs for any additional remarks.
目前沒有其他問題。我想把電話會議交回給 Mr. Jacobs,請他做任何補充說明。
Joey A. Jacobs - Chairman and CEO
Joey A. Jacobs - Chairman and CEO
Thanks, everyone, for your time this morning to be on the call about Acadia Healthcare. We've had a great first quarter, and I want to thank Ron Fincher and his operations team and all of the 40,000 plus employees throughout the company that worked so hard taking care of our patients. I was with all of our business office directors here in the U.S. yesterday, and they were very excited and I think felt good about the company and what we're doing, and I'll be leaving today to go work on a possible joint venture partner opportunity. So we're busy, all of us are busy, and we thank you for your interest in the company. Have a good day.
感謝各位今天早上撥冗參加關於 Acadia Healthcare 的電話會議。我們第一季表現非常出色,我要感謝 Ron Fincher、他的營運團隊,以及全公司超過 40,000 名員工的辛勤付出,照顧我們的病患。我昨天在美國這邊與我們所有的業務辦公室主管在一起,他們都非常振奮,我想也對公司以及我們正在做的事情感到很有信心;而我今天也將出發,去洽談一個可能的合資夥伴機會。所以我們很忙,我們大家都很忙,也感謝各位對公司的關注。祝各位有美好的一天。
Operator
Operator
And this concludes today's call. Thank you for your participation. You may now disconnect.
今天的電話會議到此結束。感謝各位的參與。您現在可以掛線。